Brian Park, PharmD

Drug Information Specialist https://www.clinicaladvisor.com

Brian Park, PharmD, is a Drug Information Specialist at MPR. A graduate of the Ernest Mario School of Pharmacy, Rutgers University, Brian worked as a pharmacy manager at Stop & Shop Pharmacy for 8 years. He is a certified diabetes care pharmacist.

All articles by Brian Park, PharmD

Pediatrics Information Center

FDA Denies Approval of Long-Acting Pediatric Growth Hormone Therapy

Brian Park, PharmD

January 25, 2022

Pfizer is evaluating the FDA’s comments in the CRL and will work with the Agency to determine the appropriate steps forward.

Ob/Gyn Information Center

COVID-19 Vaccination Does Not Impact Fertility, Study Says

Brian Park, PharmD

January 24, 2022

Participants were asked to report on COVID-19 vaccination status and prior SARS-CoV-2 infection, in addition to income and education levels, lifestyle, and reproductive and medical histories.

News

Oral Contraceptive With Novel Estrogen Under FDA Review

Brian Park, PharmD

January 21, 2022

The novel combined oral contraceptive pill includes estetrol 15mg (E4) and drospirenone 3mg (DRSP).

Asthma Information Center

Tezspire Now Available for Treatment of Severe Asthma

Brian Park, PharmD

January 14, 2022

Tezspire is a first-in-class human monoclonal antibody that works by blocking thymic stromal lymphopoietin, an epithelial cytokine involved in the initiation and persistence of airway inflammation.

Pediatrics Information Center

Monoclonal Antibody Therapy for COVID-19 Authorized for Children

Brian Park, PharmD

December 6, 2021

The expanded authorization was based on data from the phase 2/3 BLAZE-1 trial.

Infectious Diseases Information Center

ACIP Recommends Updates to Pneumococcal Vaccination Guidelines

Brian Park, PharmD

October 25, 2021

The update applies to patients who have not previously received a pneumococcal conjugate vaccine or whose previous vaccination history is unknown.

Infectious Diseases Information Center

Flucelvax Quadrivalent Approval Expanded to Include Younger Patients

Brian Park, PharmD

October 20, 2021

The expanded approval was based on data from a phase 3 study that compared Flucelvax Quadrivalent to a US-licensed comparator quadrivalent influenza vaccine.

Cardiovascular Disease Information Center

USPSTF: Starting Aspirin in Patients 60 or Older for Primary CVD Prevention Not Recommended

Brian Park, PharmD

October 14, 2021

Starting aspirin in patients 60 years or older to prevent a first heart attack or stroke is not recommended.

Infectious Diseases Information Center

Emergency Use Request Submitted for Molnupiravir for Mild to Moderate COVID-19

Brian Park, PharmD

October 14, 2021

The submission is based on data from the phase 3 MOVe-OUT trial, which evaluated molnupiravir in 775 nonhospitalized adults with mild to moderate COVID-19.

Gastroenterology Information Center

Risk of Chronic Otitis Media With Effusion Up in GERD Patients

Brian Park, PharmD

October 13, 2021

Researchers conducted a retrospective, propensity score-matched cohort study using data from the Korea National Health Insurance Service.

Next post in Gastroenterology Information Center